Dividend Information and Latest News on Abbott Laboratories Ahead of Its Ex-Dividend Date on Jul 15, 2025

Abbott Laboratories has announced a forthcoming dividend, with an ex-dividend date set for Jul 15, 2025. The dividend announcement was made on Jun 13, 2025, and shareholders can expect their dividends on Aug 15, 2025, at a rate of $0.590 per share. This figure is notably higher than the average of the last ten dividends, which stands at $0.287 per share. The company had previously issued a dividend of $0.590 per share on May 15, 2025. Both dividends are categorized as cash dividends.

Recently, Abbott Laboratories experienced a notable shift in its stock value, reflecting broader market trends. As of late, Abbott's stock closed at $132.02, marking a 1.18% decrease from its previous close. Meanwhile, analysts have reiterated a positive outlook for Abbott Laboratories, with TD Cowen maintaining a "Buy" rating and a target price of $145. This reflects confidence in Abbott's standing as a $229 billion healthcare leader. Over the past week, Abbott Laboratories has been highlighted for its strong performance against the S&P 500 index, with a notable 18% rise in stock price year-to-date, suggesting robust market positioning.

Since the last update, Abbott Laboratories has garnered attention from analysts and investors alike. Barclays has adjusted its target price, now set at $159, reaffirming a "Buy" rating, which underscores the company’s promising financial health and strategic initiatives. Furthermore, recent investments have seen Cerity Partners LLC acquiring 501,200 shares, highlighting institutional confidence in Abbott's potential for growth. This activity aligns with Oppenheimer’s continued "Outperform" rating, reinforcing a bullish sentiment around the company's future prospects.

In conclusion, Abbott Laboratories presents a compelling case for investors, backed by strong financial fundamentals and a positive outlook from industry analysts. The upcoming ex-dividend date on Jul 15, 2025, is crucial for investors looking to benefit from the dividend; purchasing shares after this date will not entitle them to receive the dividend for this cycle.